1.0
May 28, 2015
Recommend
CEO approval
Business Outlook
Pros
Pretty good products, aggressive contracting with decent formulary status for small molecule compounds, benefits are okay, company car, salaries are decent, very aggressive DTC advertising increases product visibility
Cons
horrendous culture, everyone is miserable but afraid to speak up due to fear of retaliation, Horrible management, constant realignment and restructuring (on average every 1-1.5 years), bonus potential is terrible, salaries are stagnant, inability to develop worthwhile products in-house, constantly cutting benefits, management pleads pauper while executives take home annual massive pay increases, over reliance on consultants, certain policies are extremely demeaning, company is extremely reactionary